Pulmonx Corporation LUNG Cash Flow Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| -$54M+4.2% | -$56.39M+7.3% | -$60.84M-3.3% | -$58.92M-21.1% | ||
| $1.05M-29.4% | $1.49M-3.6% | $1.55M+2.3% | $1.51M+74.5% | ||
| $21.23M-7.5% | $22.96M+3.9% | $22.1M+34.4% | $16.45M+56.2% | ||
| —— | $50K+308% | -$24K+51.0% | -$49K-917% | ||
| $53K+1.9% | $52K+8.3% | $48K-14.3% | $56K-47.2% | ||
| -$1.08M— | —— | $3.1M+31.7% | $2.36M— | ||
| $765K— | —— | -$918K— | —— | ||
| —— | —— | -$345K— | —— | ||
| —— | —— | $3.18M+2,032% | $149K-96.9% | ||
| —— | $546K+1,417% | $36K-26.5% | $49K-77.8% | ||
| —— | —— | —— | —— | ||
| $201K— | —— | —— | —— | ||
| $1.45M-21.5% | $1.84M-31.3% | $2.69M+7.5% | $2.5M+5.8% | ||
| —— | —— | —— | —— | ||
| -$955K+51.0% | -$1.95M+38.8% | -$3.18M-44.8% | -$2.2M+12.7% | ||
| -$32.38M-2.7% | -$31.54M+16.1% | -$37.61M+16.6% | -$45.08M-8.9% | ||
| $452K-68.8% | $1.45M+79.3% | $807K-38.8% | $1.32M-64.1% | ||
| —— | $27.91M-39.6% | $46.2M-2.1% | $47.19M-10.3% | ||
| $36.59M-21.9% | $46.84M+4.1% | $45M+1.6% | $44.28M+343% | ||
| $30.5M+74.5% | $17.48M+971% | -$2.01M— | —— | ||
| —— | $0— | —— | $0— | ||
| $100K— | —— | —— | —— | ||
| $249K+14.2% | $218K-29.7% | $310K-51.9% | $644K-65.6% | ||
| $900K-35.0% | $1.39M-93.5% | $21.4M+785% | $2.42M-45.7% | ||
| —— | —— | —— | —— | ||
| -$1.15M— | —— | -$18.18M+61.1% | -$46.74M+43.7% | ||
| $3.11M-10.6% | $3.48M+16.7% | $2.98M+252% | $847K+17.3% | ||
| $468K-15.8% | $556K+11.2% | $500K+25.6% | $398K+23.6% | ||
| $379K-76.5% | $1.62M+57.7% | $1.03M+402% | $204K+446% | ||
| $53K+1.9% | $52K+8.3% | $48K-14.3% | $56K-47.2% | ||
| —— | $50K+308% | -$24K+51.0% | -$49K-917% | ||
| -$955K+51.0% | -$1.95M+38.8% | -$3.18M-44.8% | -$2.2M+12.7% | ||
| —— | $436K— | —— | —— | ||
| $143K— | —— | —— | $485K-59.1% | ||
| $1.45M-21.5% | $1.84M-31.3% | $2.69M+7.5% | $2.5M+5.8% | ||
| $1.05M-29.4% | $1.49M-3.6% | $1.55M+2.3% | $1.51M+74.5% | ||
| —— | —— | —— | —— | ||
| $36.59M-21.9% | $46.84M+4.1% | $45M+1.6% | $44.28M+343% | ||
| —— | —— | —— | —— | ||
| —— | $1.24M— | —— | —— | ||
| —— | —— | —— | —— | ||
| —— | —— | —— | —— | ||
| —— | —— | —— | —— | ||
| —— | —— | —— | —— | ||
| -$955K+51.0% | -$1.95M+38.8% | -$3.18M-44.8% | -$2.2M+12.7% | ||
| —— | —— | —— | —— | ||
| $468K-15.8% | $556K+11.2% | $500K+25.6% | $398K+23.6% | ||
| -$32.83M+0.5% | -$32.98M+14.1% | -$38.42M+17.2% | -$46.4M-3.0% | ||
| -$32.83M+0.5% | -$32.98M+14.1% | -$38.42M+17.2% | -$46.4M-3.0% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Pulmonx Corporation generate?
- Pulmonx Corporation (LUNG) generated -$29.3M in operating cash flow over the trailing twelve months.
- What is Pulmonx Corporation's free cash flow?
- After $160.0K of capital expenditures, Pulmonx Corporation's free cash flow was -$29.4M over the trailing twelve months, up 14.2% year over year.
- Where does Pulmonx Corporation's cash flow data come from?
- Every line is extracted from Pulmonx Corporation's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
